(Q44013969)

English

Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus (English)

1 reference

Europe PubMed Central

28 November 2017

type 2 diabetes

0 references

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Menger Chung

1

1 reference

Europe PubMed Central

28 November 2017

Ione Kourides

2

1 reference

Europe PubMed Central

28 November 2017

William Canovatchel

3

1 reference

Europe PubMed Central

28 November 2017

Tamara Sutfin

4

1 reference

Europe PubMed Central

28 November 2017

Michael Messig

5

1 reference

Europe PubMed Central

28 November 2017

Rochelle L Chaiken

6

1 reference

Europe PubMed Central

28 November 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

28 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

28 November 2017

42

1 reference

Europe PubMed Central

28 November 2017

6

1 reference

Europe PubMed Central

28 November 2017

651-657

1 reference

Europe PubMed Central

28 November 2017

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM.

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47)

1 reference

https://api.crossref.org/works/10.1177%2F00970002042006007

21 January 2018

Identifiers

10.1177/00970002042006007

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44013969&oldid=2144471990"